Search PubMed⌕ Search

Biomedical subjects

B Lindelöf

Publications and source records attributed to B Lindelöf.

At least 55 records · Page 3Linked to original sources
PubMed1990

Pemphigoid and cancer.

To evaluate the significance of the association of malignant disease with bullous pemphigoid, we reviewed 497 consecutive cases with positive immunofluorescence tests for circulating antibodies to basement membrane. We searched the Swedish Cancer Registry, Stockholm, Sweden, for records reporting malignancies in the study population (1958 to 1985), and the expected number of malignancies was calculated on the basis of age- and sex-standardized incidence data. In 61 patients, a total of 69 malignancies were diagnosed. The expected number of malignancies was 82.6. In 25 patients, a total of 27 malignancies appeared during the same year as the onset of pemphigoid, or later. The expected number was 35.8. The median titer of circulating antibodies in the 497 patients, in the 61 patients with malignancy, and in the 25 patients with malignancy preceded by the pemphigoid, were not significantly different. We conclude that pemphigoid is not statistically associated with malignancy, and that the former hypothesis of such an association was based on age only.

Adult↗
PubMed1990

The prevalence of malignant tumors in patients with psoriasis.

A possible association between psoriasis and cancer was investigated by linking the Swedish Psoriasis Association's membership registry to the Swedish Cancer Registry. The population studied was 20,328 living persons. Since 1958 a cancer was recorded in 520 of them. The expected number, based on the prevalence of cancer in Sweden, was 540. Among 43 cancer sites for men and 46 for women selected primarily for analysis, a significant association with psoriasis was found only in two types of cancer. For male breast cancer the observed number was 4 and the expected number was 0.58, and for female kidney cancers the observed number was 17 and the expected number was 6.1. The statistically significant excess risk found for these two forms of cancer may be the result of multiple statistical testing rather than a phenomenon of true biologic significance. Thus psoriasis patients seem not to deviate from the general population with regard to cancer prevalence.

Adolescent↗
PubMed1990

Chronic urticaria and cancer: an epidemiological study of 1155 patients.

To evaluate the possible association of malignant disease with chronic urticaria 1155 consecutive cases with chronic urticaria were reviewed. The Swedish Cancer Registry, Stockholm, was searched for records reporting malignancies in the study population (1958-84), and the expected number of malignancies was calculated on the basis of age- and sex-standardized incidence data. A malignancy was diagnosed in 36 patients with urticaria and the expected number of malignancies was 41. In 23 patients the malignancy appeared during the same year as the onset of urticaria or later. The expected number was 25.6. We conclude that chronic urticaria is not statistically associated with malignancy in general.

Adolescent↗
PubMed1990

The effect of grenz ray therapy on pustulosis palmoplantaris. A double-blind bilateral trial.

The effect of grenz ray therapy in the treatment of pustulosis palmoplantaris was assessed in 15 patients by randomly allocating active treatment of the lesions of one side of the body, while the lesions on the other side, which received stimulated therapy, served as a control. Four Gy of grenz rays 10 kV were applied on 6 occasions at intervals of 1 week. A significantly better therapeutic result was recorded on the lesions which had received active grenz ray therapy. However, the therapeutic response was moderate. It is concluded that grenz ray therapy could be useful in pustulosis palmoplantaris mainly as an adjunct to other therapies.

Adult↗
PubMed1989

Influence of grenz rays and psychological factors on experimental pruritus induced by histamine and compound 48/80.

The interaction between grenz rays and experimentally induced pruritus was evaluated in 14 healthy subjects. Grenz rays were administered once weekly for 4 weeks on restricted areas of the upper arms. Pruritus was evoked by intradermal injection of histamine and the histamine liberator compound 48/80. The results were compared with unconditioned values and with those obtained following a placebo treatment procedure. The influence of psychosocial and psychosomatic factors was also evaluated. Grenz-ray therapy reduced itch but not flare responses. The influence of grenz rays was, however, not statistically different from that observed after placebo treatment. Psychosocial and psychosomatic factors were good predictors of individual skin responsiveness. The results indicate that grenz rays do not interfere with experimental histamine-induced pruritus more than placebo and emphasize the importance of knowing individual characteristics and coping strategies.

Adult↗
PubMed1989

The duration of Grenz ray-induced suppression of allergic contact dermatitis and its correlation with the density of Langerhans cells in human epidermis.

Recent investigations have shown that Grenz rays can suppress the allergic contact dermatitis reaction completely and that Langerhans cells, identified by OKT6 antibodies and electron microscopy, disappear from the epidermis at the same time. It is not known for how long this suppression lasts. This has been investigated in 28 nickel-sensitive patients who were given Grenz rays (3 Gy) on the back, once a week for 3 weeks. The patients were then divided into four groups and tested with patch tests for nickel at 1, 7, 14 and 21 days after the last Grenz ray treatment. Biopsies were taken from positive patch test sites, and from the corresponding opposite control. They were labelled with OKT6 antibodies to detect Langerhans cells. The patch test reactions were suppressed and the Langerhans cell density was decreased initially. These changes were restored after 3 and 6 weeks, respectively. The results show that the effect of Grenz rays on eczematous reactions extends to a maximum of 3 weeks and imply that Langerhans cells are necessary for the elicitation of the efferent phase of allergic contact dermatitis.

Adolescent↗
PubMed1989

Psoriasis of the nails treated with grenz rays: a double-blind bilateral trial.

The effect of grenz ray therapy in the treatment of psoriatic nails was assessed in 22 patients by randomly allocating active treatment to the psoriatic nails of one hand while the other one, which received simulated therapy, served as a control. Five Gy of grenz rays were applied on 10 occasions at intervals of 1 week. There was a significantly better response to active treatment compared with the untreated control. However, the therapeutic response was moderate. It is concluded that grenz ray therapy could be useful only when the psoriatic nails are of normal thickness.

Adult↗
PubMed1989

[Grenz ray therapy].

Grenz rays (ultrasoft X-rays, Bucky rays) have been used in the treatment of benign skin disorders for more than 60 years. The mechanism of action, the clinical effect and the potential carcinogenic effect have remained largely unknown, and many of the reported studies are now obsolete. Recent studies of both the clinical and the basic characteristics of grenz rays have shown that the number of Langerhans' cells decreases in the human epidermis after treatment and that grenz rays can suppress the expression of nickel allergy in sensitive individuals. Also, very good results have been reported in the treatment of psoriasis of the scalp. A large-scale study involving more than 14,000 patients has shown that grenz ray therapy cannot be excluded as a risk factor in the development of non-melanoma skin tumors, but this risk factor is small and can virtually be disregarded when certain therapy recommendations are followed. This article is an attempt to summarize the present knowledge of grenz ray therapy.

Humans↗
PubMed1988

Histiocytosis X in an adult: treatment of skin lesions with grenz rays.

One adult woman patient with skin lesions typical of histiocytosis X was treated with grenz rays (ultrasoft X rays). She had no clear systemic involvement of the disease. During a period of 2 years she has received five courses of grenz rays, which have had a marked effect on the skin lesions, especially of the scalp.

Adrenal Cortex Hormones↗
PubMed1988

Psoriasis of the scalp treated with Grenz rays or topical corticosteroid combined with Grenz rays. A comparative randomized trial.

To investigate the effect of Grenz ray therapy alone compared with Grenz rays combined with a topical corticosteroid (betamethasone dipropionate) in psoriasis of the scalp, 40 patients were randomized into two groups. One group received 4 Gy of Grenz rays administered on six occasions at intervals of 1 week and the other group was given the same Grenz ray treatment plus topical corticosteroid. The patients were assessed before and after Grenz ray therapy and were followed-up for 6 months. Of the 37 patients who completed the trial 16 out of 19 (84%) of the patients in the Grenz ray group, and 13 out of 18 (72%) of the patients in the combination group healed. The remission time did not differ significantly between the two groups. Of the patients who healed, 5 of 16 patients in the Grenz ray only group and 4 of 13 patients in the combination group remained healed at 6 months. We conclude that Grenz ray therapy is a useful treatment modality for scalp psoriasis, but that the addition of a topical corticosteroid has only a minor effect.

Administration, Topical↗
PubMed1988

Absence of mutagenic response to radiation from a video display terminal.

The standard Ames Salmonella test (TA 100) was used to detect the mutagenicity of radiation from a video display terminal. The Ames test is a sensitive assay that detects the ability of a chemical to damage deoxyribonucleic acid. It has also been employed to detect the mutagenicity of electromagnetic radiation. An extremely short distance (62 mm) from a video display terminal and an extremely high electrostatic field strength (250 kv/m) was employed. No mutagenic response was found in this test system.

Computer Systems↗